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ABSTRACT The effects of -tocopherol on the properties of model high-density lipoproteins (HDLs), composed of human
apolipoprotein A-I and dimyristoylphosphatidylcholine, were investigated by physicochemical methods. The intrinsic fluo-
rescence of -tocopherol and its effects on the polarization of fluorescence of 1,6-diphenyl-1,3,5-hexatriene, which probes
the hydrocarbon region of the lipids, and 4-heptadecyl-7-hydroxycoumarin, which is a probe of lipid surfaces, suggest that
-tocopherol is located at the lipid-water interface. Relative to cholesterol, -tocopherol in lipid surfaces is virtually inert
physicochemically. Incorporation of -tocopherol into HDLs induces only a modest increase in particle size, no change in the
transition temperature, and little change in lipid polarity and lipid-lipid interactions. Moreover, -tocopherol has only a
negligible effect on the kinetic parameters of the lipophilic enzyme lecithin:cholesterol acyltransferase, which binds to
phosphatidylcholine surfaces and forms cholesteryl esters. However, -tocopherol has a dramatic inhibitory effect on the rate
of association of apolipoprotein A-I with dimyristoylphosphatidylcholine, a process that occurs through the insertion of the
protein into preformed defects in the lipid surface. It is proposed that -tocopherol inhibits the rate of association of
apolipoprotein A-I with dimyristoylphosphatidylcholine by inserting into defects within the lipid surface, thereby reducing the
size and/or number of sites for insertion of apolipoprotein A-I.
INTRODUCTION
Vitamin E, an antioxidant that occurs largely as -tocoph-
erol, is the only significant lipid-soluble, chain-breaking
antioxidant present in human blood (Burton and Ingold,
1986; McCay, 1985). In blood, -tocopherol transfers re-
versibly among blood cells and its major carrier, lipopro-
teins (Kayden and Trayber, 1987). Additionally, -tocoph-
erol can be delivered to cells by receptor-mediated uptake of
lipoproteins that contain it (Traber and Kayden, 1984) and
by a poorly defined mechanism involving the hydrolysis of
chylomicrons by lipoprotein lipase (Traber et al., 1985).
The transport of -tocopherol among lipoproteins is impor-
tant because of its putative protective effects within a vari-
ety of cells that have been implicated in the development of
atherosclerosis. These effects include preservation of endo-
thelial function and inhibition of monocyte-endothelial cell
adhesion, smooth muscle cell proliferation, monocyte-reac-
tive oxygen species and cytokine release, and platelet ad-
hesion and aggregation (Devaraj and Jialal, 1998).
Although -tocopherol transport is closely connected to
lipid and lipoprotein transport, detailed mechanisms of the
connection are not known. Through interactions with poly-
unsaturated fatty acid residues of phospholipid molecules,
-tocopherol modifies cell membrane stability and rigidity
and the lateral mobility of membrane lipids (Lucy, 1978;
Lai et al., 1985; Wasall et al., 1986; Villalain et al., 1986;
Ortiz et al., 1987; Massey et al., 1982; Ekiel et al., 1988).
The phytyl side chain appears to suppress the transfer of
-tocopherol between liposomal membranes (Niki et al.,
1985; Castle and Perkins, 1986; Massey, 1984; Murphy and
Mavis, 1981) and to modify the lateral distribution of -to-
copherol in a membrane (Ortiz et al., 1987; Massey et al.,
1982; Ekiel et al., 1988). Additionally, -tocopherol may
affect the activities of lipid-metabolizing enzymes (Napoli
and Beck, 1984; Douglas et al., 1986) and inhibit some
lipid-protein interactions (Halks-Miller et al., 1985). Studies
of -tocopherol in membranes and membrane models have
led to our broad hypothesis that -tocopherol modulates the
structure and function of the lipid-protein systems that make
up the plasma lipoproteins.
To address this hypothesis, we studied the effects of
-tocopherol on the assembly, structure, and function of
model HDLs consisting of 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) and either apolipoprotein (Apo)A-
I or ApoA-II. Model HDLs are a well characterized system
that has been widely used to study the effects of cholesterol
in plasma lipoprotein structure and function (Pownall et al.,
1978, 1979, 1985, 1987; Massey et al., 1985a,b,c; Matz and
Jonas, 1982; Reijngould and Phillips, 1984) and offer a
simple system with which to investigate its effects on li-
poprotein structure and lipid-protein interactions. Although
there have been several studies of the effects of -tocoph-
erol on phospholipid bilayers (Lai et al., 1985; Wasall et al.,
1986; Villalain et al., 1986; Ortiz et al., 1987; Massey et al.,
1982; Ekiel et al., 1988), none has addressed the effects of
-tocopherol within a lipid system containing a lipid-asso-
ciating protein. Such information may aid our understand-
ing of the role of HDLs in the lipoprotein-dependent trans-
port of vitamin E (Kayden, 1981).
EXPERIMENTAL PROCEDURES
Materials
ApoA-I, ApoA-II, and lecithin:cholesterol acyl transferase (LCAT) were
isolated from human plasma as previously described (Pownall et al., 1985;
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Massey et al., 1985a). DMPC was obtained from Avanti Polar Lipids
(Birmingham, AL). [3H]Cholesterol was from New England Nuclear (Bos-
ton, MA), and [3H]DMPC was synthesized as previously described (Pown-
all et al., 1978). -Tocopherol (95% pure) was a gift from the Henkel Corp.
and was further purified by chromatography over alumina using a 0–4%
gradient of ethyl acetate in hexane. The product was detected and quanti-
fied on the basis of the spectral absorption at 290 nm and by reaction with
2,2-diphenyl-1-picrylhydrazyl (DPPH) (Bellemare and Fragata, 1980). The
resulting purity was99% as determined by thin-layer chromatography on
silica gel, using a solvent of ethyl acetate/hexane (10:90 v:v) and identi-
fication by iodine staining, spraying with DPPH, or spraying with acid and
then charring. DPPH was from Aldrich Chemical Co. (Milwaukee, WI).
Prodan, 4-heptadecyl-7-hydroxycoumarin (HC), and 1,6-diphenyl-1,3,5-
hexatriene (DPH) were from Molecular Probes (Grand Junction, OR).
Methods
Kinetics of ApoA-I/DMPC association
The rate of ApoA-I association with multilamellar liposomes of DMPC
containing various concentrations of -tocopherol was determined by
measuring the rate of decrease of liposomal turbidity (Pownall et al., 1978,
1979). DMPC/-tocopherol liposomes were prepared by co-solubilizing
the desired quantity of each lipid in chloroform, removing the solvent
under a stream of nitrogen, and lyophilizing. The dried lipids were dis-
persed by vortexing for a few minutes above the DMPC transition tem-
perature (23.9°C) in a buffer of 100 mM NaCl, 1 mM sodium azide, 1
mM ethylenediaminetetraacetic acid, and 10 mM Tris, pH 7.4; this buffer
was used throughout. The liposomes and ApoA-I were preincubated at the
appropriate temperature and then mixed for a final concentration of lipo-
somes (0.5 mg of phospholipid) and ApoA-I (0.2 mg) in a final volume of
3 ml. Rates of association were measured by following the reduction in
right-angle light scattering versus time in an SLM 8000 spectrofluorimeter
(Urbana, IL) with excitation and emission wavelengths of 325 nm. The
samples were continuously stirred to prevent settling of the liposomes. The
data were analyzed according to pseudo-first-order kinetics, where the rate
constant k1/2  1/t1/2, with t1/2 representing the time for disappearance of
50% of the light-scattering intensity.
Preparation of model HDLs
Model HDLs were formed by spontaneous association or by dialysis from
mixed micelles of cholate. In the first method, liposomes containing
various amounts of -tocopherol were prepared by dissolving DMPC and
-tocopherol in chloroform, removing the solvent under a stream of nitro-
gen, and suspending the dried lipids in buffer by vortexing above the
transition temperature (24°C). ApoA-I (1 mol % DMPC) was added and
incubated with the liposomes for 24 h at 24°C (Massey et al., 1985b;
Pownall et al., 1978). In the second method, DMPC was solubilized in
cholate until the solution was transparent; ApoA-I was then added and the
detergent was removed by extensive dialysis at room temperature (Massey
et al., 1985b). The model HDLs were isolated by chromatography over
Sepharose CL-4B (1.6  40 cm) at ambient temperature. The column
effluent was monitored by scintillation counting of [3H]DMPC and absor-
bance at 280 nm. Pooled fractions were analyzed for phospholipid (Barlett,
1959) and protein (Lowry et al., 1951). The -tocopherol concentration
was determined from its absorbance after extraction into organic solvents.
To determine the Stoke’s radius (Ro), pooled fractions from the Sepha-
rose CL-4B column were concentrated using Amicon Centricon microcon-
centrators (Amicon, Beverly, MA) and analyzed by analytical gel filtration
on two Superose HR6 columns (Pharmacia, Piscataway, NJ) connected in
tandem; 200-l aliquots were collected and monitored for absorbance at
280 nm. The Stoke’s radius was determined by comparison with the
following standards: thyroglobulin (Ro  85 Å), ferritin (Ro  61 Å),
catalase (Ro  52 Å), aldolase (Ro  48 Å), bovine serum albumin (Ro 
36 Å), ovalbumin (Ro  31 Å), chymotrypsin (Ro  21 Å), and ribonu-
clease A (Ro  16 Å). Sonicated DMPC single-bilayer vesicles (Ro  125
Å) and human low-density lipoprotein (LDL) (Ro  105 Å) were also run
as standards. The column parameter KAV was calculated as KAV  (Ve 
V0)/(Vt V0), where Ve is the elution volume of the model HDLs, V0 is the
void volume determined by using [3H]DMPC liposomes, and Vt is the salt
peak determined using [14C]phosphorylcholine (Massey et al., 1981).
Fluorescence methods
Fluorescence polarization of DPH (Massey et al., 1985b) and HC (Pal et
al., 1985) in model lipoproteins was measured on an SLM 8000 spec-
trofluorimeter equipped with Glan-Thompson prisms. DPH was chosen to
measure the mobility of the acyl chain region of the bilayer, and HC was
chosen because it is sensitive to the motion at the interfacial head group
regions of a phospholipid bilayer (Pal et al., 1985). The fluorescence
probes were introduced by injection of microliter aliquots of the probe in
ethanol into the samples. Final concentrations were 0.1% by volume of
ethanol and contained 1 mol of probe per 500 mol of phospholipid. The
sample chamber was maintained at a constant temperature with a thermo-
stat-controlled water bath, and the temperature in the cuvette was recorded
with a Bailey Instruments digital thermometer (model Bat 8). The respec-
tive excitation wavelengths were 375 nm and 350 nm for for HC and DPH.
The intensity of the emitted light was measured after passing through a
Corning 3–144 cutoff filter. The Prodan fluorescence spectra were mea-
sured and analyzed for spectral width and the wavelength of maximal
intensity (Massey et al., 1985c). On the basis of the partition coefficient
previously determined for Prodan with model HDLs (Massey et al., 1985c),
conditions were selected so that 99% of the probe was associated with
phospholipid.
LCAT measurements
The effect of -tocopherol on the reactivity of model HDLs to the reaction
catalyzed by LCAT was determined (Pownall et al., 1985; Massey et al.,
1985a). Model HDLs composed of ApoA-I (1 mol %), DMPC (97 mol %),
and [3H]cholesterol (2 mol % cholesterol) were prepared by using the
cholate dialysis method described above. Other model HDLs containing
-tocopherol in amounts up to 8 mol % of the DMPC were prepared
similarly except that -tocopherol was added to the DMPC before lyoph-
ilization and hydration. These HDL models were used as substrates for
LCAT according to previously described experimental procedures (Pown-
all et al., 1985; Massey et al., 1985a). Enzymatic activity was determined
as a function of model HDL phospholipid concentration, and the maximal
enzymatic velocities (VMAX) and apparent Michaelis–Menten constants
(KM) were determined.
Microenvironment and reactivity of -tocopherol in
model HDLs
Fluorescence spectra of -tocopherol in model HDLs containing ApoA-II
were recorded on an SLM 8000 spectrofluorimeter. The microenvironment
and reactivity of -tocopherol were determined in previously characterized
(Massey, 1984; Massey et al., 1981) model HDLs composed of ApoA-II
and DMPC (1/75 molar ratio of lipid to protein (M/M)). These models were
used because ApoA-II has a spectral window at 290 nm where -tocoph-
erol has an absorption maximum. This window permits the environment of
-tocopherol to be directly examined from the fluorescence spectrum of
the chromanol ring in -tocopherol. To determine the accessibility of the
chromanol ring system to the aqueous solvent, D2O was used as a pertur-
bant (Massey and Pownall, 1989).
To assess the reactivity of -tocopherol in model HDLs, the kinetics of
reductive bleaching of DPPH by -tocopherol were determined by a
previously described method (Bellemare and Fragata, 1980). In essence,
the rate of DPPH bleaching was followed by measuring the absorbance at
516 nm as a function of time. A Cary model 15 spectrophotometer was
used with the temperature of the cell holder maintained by a Neslab water
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bath and monitored by a Bailey Instruments digital thermometer (model
Bat 8) with thermocouple.
RESULTS
Gel filtration chromatography
The size and extent of formation of model HDLs formed by
the association of ApoA-I and DMPC were analyzed by gel
filtration chromatography over Sepharose CL-4B. The cri-
terion for the formation of model HDLs is the co-elution of
the lipid and protein; size was assessed on the basis of
elution volume. At 0, 1, 3, and 6 mol % -tocopherol, the
ApoA-I and DMPC eluted as a single, homogeneous peak,
but at 12, 18, and 24 mol % -tocopherol, most of the
liposomes eluted in the void volume (data not shown). To
“catalyze” the formation of model HDLs (Massey et al.,
1985b), mixtures of ApoA-I, DMPC, and -tocopherol
were solubilized in cholate and the cholate was removed by
dialysis. The range of -tocopherol concentrations in
DMPC extended from 0 to 30 mol %. Representative data in
Fig. 1 show that at 0, 12, 24, and 30 mol % -tocopherol,
nearly all of the lipid and protein co-eluted as a single
product with no lipid appearing in the void volume, indi-
cating that the association of ApoA-I and DMPC is nearly
quantitative. Pooled samples from incubations containing a
wide range of mol % -tocopherol were analyzed by Su-
perose 6 gel filtration chromatography. In mixtures contain-
ing up to 12 mol % -tocopherol in DMPC liposomes,
homogeneous model HDLs having similar Stoke’s radii
were formed by spontaneous association and by cholate
dialysis. At higher mol % -tocopherol in DMPC, the
distribution of size among the model HDLs was bimodal
(Fig. 2). The chromatographic data showed that with the
cholate dialysis method, the -tocopherol and DMPC were
quantitatively incorporated into model HDLs identical in
composition to the initial mixtures (Figs. 2 and 3 A). Fur-
thermore, these data show that as the mol % -tocopherol in
DMPC was increased the DMPC to ApoA-I ratio decreased
slightly (Fig. 3 B), and the size of the model HDLs de-
creased (Figs. 2 and 3 C).
Fluorescence polarization
The phase behavior of the lipid matrix in the model HDLs
formed by the cholate dialysis method was investigated by
measuring the temperature dependence of the fluorescence
polarization of DPH and HC, which are sensitive to changes
in mobility within the hydrocarbon and surface regions,
respectively, of lipids and lipoproteins (Massey et al.,
1985b; Pal et al., 1985). The temperature of the midpoint of
the change in the fluorescence polarization, which corre-
sponds to the gel-to-liquid crystalline transition (TC 
28°C) of the model HDLs, was invariant with respect to an
-tocopherol content between 0 and 24 mol %. According
to the polarization of fluorescence of DPH, -tocopherol
modulates the phase behavior of DMPC in the model HDLs
FIGURE 1 Sepharose CL-4B gel filtration of model HDLs of ApoA-I
and -tocopherol/DMPC liposomes. DMPC (5 mg) and different amounts
of -tocopherol were incubated with ApoA-I (2 mg) and 10% sodium
cholate for 24 h at 24°C. The samples were exhaustively dialyzed against
a buffer and applied to a column of Sepharose CL-4B. The elution profile
was determined by collecting fractions and analyzing an aliquot for [3H]D-
PMC by liquid scintillation counting. Elution profiles are for model HDLs
formed from ApoA-I and DMPC containing 1, 12, 24, and 30 mol %
-tocopherol. Pooled samples were formed as follows: F, 0 mol %,
fractions 22–26; Œ, 12 mol %, fractions 22–26; , 24 mol %, fractions
19–22 (pool A) and fractions 23–27 (pool B); , 30 mol %, fractions
19–22 (pool A) and fractions 23–27 (pool B).
FIGURE 2 Superose 6 gel filtration chromatography of model HDLs
containing -tocopherol. Pooled samples as described in Figure 1 were
applied to a Superose 6 column, and the effluent was monitored by
measuring the absorbance at 280 nm. (A) 0 mol % -tocopherol; (B) 12 mol
% -tocopherol; (C) 30 mol % -tocopherol, pool A; (D) 30 mol %
-tocopherol pool B. The elution volumes of standards are shown at the top
of the figure with their respective Stoke’s radii (Å).
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(Fig. 4 A). Below the transition temperature, incorporation
of -tocopherol into the model HDLs decreased the polar-
ization of the fluorescence of DPH, whereas above the
transition temperature the opposite was observed. This is
consistent with -tocopherol’s increasing the fluidity below
the transition temperature and decreasing it above the tran-
sition temperature. A similar effect was observed with HC
except that below the transition temperature, -tocopherol
had no effect on the polarization of HC fluorescence (Fig. 4 B).
Prodan fluorescence
The fluorescence spectrum of Prodan is sensitive to the
quality of its microenvironment (Massey et al., 1985c). The
spectral location of the fluorescence maximum reflects the
polarity of the microenvironment and the spectral half-
width gives an indication of the heterogeneity of the micro-
environment. The change in the phase state of the phospho-
lipid elicited a dramatic change in the emission maximum
and the spectral half-width of the fluorescence (Fig. 5). In
FIGURE 3 Effects of different amounts of -tocopherol on the physi-
cochemical properties of model HDLs. Model HDLs were prepared by
spontaneous association (E and ‚) and by the cholate dialysis method (),
and the major subfractions were isolated by Superose 6 chromatography.
The isolated samples were analyzed for -tocopherol, DMPC, and ApoA-I.
On the basis of these analyses, the mol % -tocopherol in DMPC and the
DMPC/ApoA-I ratios were calculated. These values and the Stoke’s radii
in Å were plotted against the mol % -tocopherol in the starting mixture.
(A) mol % -tocopherol in DMPC; (B) DMPC to ApoA-I molar ratio; (C)
Stoke’s radius. Spontaneous association experiments 1 () and 2 (‚) were
conducted on different days.
FIGURE 4 Temperature dependence of the fluorescence polarization of
DPH and HC in model HDLs containing different amounts of -tocoph-
erol. (A) DPH polarization; (B) HC polarization. The model HDLs con-
tained 0 (F), 6 (f), 12 (), or 24 (Œ) mol % -tocopherol.
FIGURE 5 Temperature dependence of the fluorescence behavior of
Prodan in model HDLs containing different amounts (n) of -tocopherol.
Model HDLs were composed of ApoA-I/DMPC (1/100). (A) Fluorescence
spectra of Prodan in model HDLs at different (denoted) temperatures; (B)
Wavelength maximum (-tocopherol content in the model HDLs was 0
mol % (Œ) or 24 mol % (F)); (C) Spectral half-width (1/2) (0 mol % (Œ),
12 mol % (), 18 mol % (f), and 24 mol % (F))
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contrast, the fluorescence of Prodan in model HDLs was
only slightly sensitive to the addition of up to 24 mol %
-tocopherol (Fig. 4); the fluorescence maxima were nearly
the same at 0 and 24 mol % -tocopherol (Fig. 5 B).
Fluorescence half-width, which is a measure of microscopic
heterogeneity, was modulated by the addition of -tocoph-
erol (Fig. 5 C). Below the transition temperature, where
small values of 1/2 were observed, incorporation of -to-
copherol into the model HDLs increased the fluorescence
half-width; above the transition temperature, where large
values of 1/2 were observed, the addition of -tocopherol
decreased the value of 1/2.
Spectral and chemical behavior of -tocopherol
in model HDLs
To identify the effects of the phase transition of DMPC on
the microenvironement of -tocopherol, the fluorescence
properties of the chromanol ring of -tocopherol were mon-
itored in model HDLs of ApoA-II and DMPC (Massey,
1984; Massey et al., 1981; Massey and Pownall, 1989).
There was only a slight red shift in the fluorescence maxi-
mum of -tocopherol in liquid crystalline (T  50°C)
compared with gel-phase DMPC (T  10°C; Fig. 6 A).
Replacement of H2O with D2O increased the fluorescence
quantum yield and induced a slight blue shift in the fluo-
rescence maximum. As replacing H2O with D2O alters the
spectral properties of the chromanol moiety, -tocopherol
must be accessible to water. On the other hand, the chro-
matographic data show that -tocopherol is bound to the
lipids. Moreover, the discontinuity in the ratio of the fluo-
rescence intensity of D2O versus H2O with respect to tem-
perature, observed at the phase-transition temperature
(28°C) of DMPC in model HDLs suggests that -tocopherol
interacts with the hydrocarbon region of DMPC. These data
suggest that the chromanol ring of -tocopherol is in the
aqueous-lipid interfacial region of the bilayer, where it is
accessible to the aqueous phase. The higher quantum yield
in D2O above 28°C suggests that the accessibility of the
chromanol ring to the aqueous solvent is greater above the
phase transition (Fig. 6 B). The rate of reaction of -tocoph-
erol with DPPH (Bellemare and Fragata, 1980) was mea-
sured as a function of temperature. Below the phase transi-
tion (T  20°C), the rate was slow, and as the temperature
increased the rate increased gradually until the DMPC tran-
sition temperature was reached, when the rate increased
dramatically (Fig. 6 B).
LCAT activity
The effect of -tocopherol on the activity of LCAT was
determined by using model HDLs containing 2 mol %
cholesterol. The values for KM and VMax, which were de-
termined from steady-state kinetic measurements (Pownall
et al., 1985; Massey et al., 1985a) were the same for model
HDLs having between 0 and 8 mol % -tocopherol (Fig. 7).
Kinetics of association of ApoA-I with
DMPC liposomes
Association of saturated phospholipids and apolipoproteins
is a function of temperature and the addition of small
FIGURE 6 Spectral behavior and chemical reactivity of -tocopherol in
model HDLs. Model HDLs were composed of ApoA-II, DMPC, and
-tocopherol (1/75/1 M/M/M). (A) Fluorescence spectra of -tocopherol at
10°C and 50°C in H2O (- - -) and 95% D2O (——). Arrows indicate the
wavelength maximum for each spectrum. (B) The ratio of the maximal
fluorescence intensity in D2O (ID2O) versus that observed in H2O (IH2O)
was calculated and plotted as a function of temperature (Œ). A disconti-
nuity is observed at Tc 28°C, the DMPC phase transition in model HDLs
(Massey et al., 1989). The relative rate of reduction of DPPH by -tocoph-
erol in the ApoA-II/DMPC complexes as a function of temperature is also
shown (F). Error bars represent standard deviation.
FIGURE 7 Effect of -tocopherol on the LCAT activity against model
HDLs. The model HDLs formed by the cholate dialysis procedure were
composed of ApoA-I, DMPC, and cholesterol (1/100/2 M/M/M) and
various amounts of -tocopherol, which are expressed in terms of mol %
of DMPC. The model HDLs contained a tracer of [3H]cholesterol to
quantify the formation of cholesteryl esters. VMax and KM were determined
from steady-state kinetics of reaction velocity versus the DMPC concen-
tration (Pownall et al., 1978, 1979).
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uncharged lipids. Association of ApoA-I with DMPC lipo-
somes exhibits a maximal rate at the transition temperature
of the lipid (Pownall et al., 1978), and incorporation of
cholesterol into the liposomes dramatically increases the
maximal rate of association (Pownall et al., 1979). The
effects of -tocopherol and temperature on the rate of
association of ApoA-I and DMPC liposomes were deter-
mined (Fig. 8). In the absence of -tocopherol, the rate of
ApoA-I–DMPC association was greatest at 24°C; however,
the rate of association was much slower above and below
this temperature. The rate of association of ApoA-I with
DMPC liposomes decreased with increased amounts of
-tocopherol in the liposomes, even with as little as 1 mol
%. At 24°C, the rate of association of ApoA-I with lipo-
somes containing 6 mol % -tocopherol was approximately
four orders of magnitude slower than that observed with
pure DMPC liposomes. In addition, the temperature at
which the maximal rate of association was observed de-
creased as a function of added -tocopherol. Incorporation
of -tocopherol into the DMPC liposomes produced two
effects, which were a decrease in the rate of association and a
reduction in the temperature of the maximal rate of association.
DISCUSSION
The modification of the physical properties of model HDLs
by -tocopherol is distinct from that of cholesterol. Al-
though incorporation of -tocopherol into model HDLs
increases their size (Fig. 2), the magnitude of the effect is
not nearly as large as that of added cholesterol, which at 24
mol % in DMPC combines with ApoA-I to form particles
that are large enough (Stoke’s radius750 nm) to be totally
excluded from Sepharose CL-4B (Massey et al., 1985b).
The effect of cholesterol on the Stoke’s radii of single-
bilayer vesicles and model HDLs is thought to be due to the
replacement of the truncated cone shape of phospholipid
with the inverted cone shape of cholesterol (Israelachvili et
al., 1980). The effect of -tocopherol on particle size is
smaller because its shape is very close to cylindrical.
The temperature dependence of the polarization of HC
and DPH fluorescence reveals differences in the phase
behavior of model HDLs containing -tocopherol and the
effects of -tocopherol on molecular mobility within the
particles. At T  TC, -tocopherol had only a small effect
on the fluorescence polarization; at T  TC, however, a
large, concentration-dependent decrease in polarization was
observed (Fig. 4, A and B). This was observed for both
DPH, which probes molecular mobility within the hydro-
carbon region of the model HDLs, and HC, which monitors
mobility within the interfacial region (Fig. 4 B). These data
suggest that above the transition temperature, -tocopherol
decreases lateral and rotational mobility in model HDLs and
that this effect extends to both the interfacial and the hy-
drocarbon regions of the particles. Although incorporation
of cholesterol into model HDLs raises its transition temper-
ature (Massey et al., 1985b), our data revealed no effect of
-tocopherol on the TC of DMPC. This suggests that -to-
copherol does not greatly modify the lipid-lipid interactions
between DMPC molecules.
The fluorescence spectral properties of Prodan, which are
highly sensitive to solvent polarity (Massey et al., 1985c,
Weber and Farris, 1979), make it a good probe of polarity
and its heterogeneity in model lipid systems. Whereas a
large Stoke’s shift is indicative of a polar environment, the
breadth of the fluorescence spectrum is a reliable indicator
of the heterogeneity of the environment around Prodan.
Unlike the effects of cholesterol, addition of -tocopherol
had only a small effect on the fluorescence properties of
Prodan. The maximal value in 1/2 occurred at the same
temperature for all concentrations studied and varied only
slightly among the different model HDLs (Fig. 5 C). The
temperature dependence of the fluorescence maximum was
only slightly different when the -tocopherol content was
increased from 0 to 24 mol % -tocopherol (Fig. 5 B). The
difference is due to -tocopherol’s broadening the phase
transition (Fig. 5 A). The effects of cholesterol on Prodan
fluorescence in model HDLs composed of ApoA-I and
DMPC are distinctly different: at 18 mol % cholesterol a
wavelength maximum characteristic of gel-phase lipid is
observed even at T  TC (Massey et al., 1985c). This result
suggested that cholesterol decreases the water penetrability
into liquid-crystalline bilayers (Massey et al., 1985c;
Straume and Litman, 1987) but that -tocopherol does not.
In model HDLs containing ApoA-I, DMPC, and [3H]cho-
lesterol, addition of up to 8 mol % -tocopherol had no
effect on cholesterol esterification by LCAT (Fig. 7). Based
on the small differences in DPH fluorescence polarization,
FIGURE 8 Kinetics of association of ApoA-I with DMPC/-tocopherol
liposomes followed by changes in turbidity as a function of mol %
-tocopherol and temperature. Liposomes (0.5 mg of phospholipid) and
ApoA-I (0.2 mg) were preincubated at the appropriate temperature and
mixed to give a final volume of 3 ml. The rate constant k1/2  1/t1/2
represents the time required for 50% reduction in light scattering at 325
nm. The data shown are for 0 mol % (F), 1 mol % (Œ), 3 mol % (f), and
6 mol % () -tocopherol.
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0 to 6 mol % -tocopherol induced little change in lipid
fluidity of model HDL substrates at the temperature of the
assay (37°C) (Fig. 4 A). Thus, even though it contains an
alcohol functional group, -tocopherol is neither a compet-
ing substrate nor a competitive inhibitor of LCAT. More-
over, -tocopherol does not modify the physical properties
of the model HDLs enough to affect LCAT activity by
means of other mechanisms.
The effect of the gel-to-liquid crystalline phase transition
on the microenvironment of -tocopherol in ApoA-II/
DMPC complexes was examined by the fluorescence prop-
erties of the chromanol ring and the chemical reactivity of
-tocopherol with DPPH (Bellemare and Fragata, 1980).
According to both methods, the microenvironment for the
chromanol ring is different in the gel and liquid-crystalline
phases and the chromanol ring is located at the lipid-water
interface (Ekiel et al., 1988). Using environmentally sensi-
tive fluorescence lipid probes and the intrinsic spectral
properties of tyrosine residues, we previously demonstrated
that the lipid-water interface of DMPC and the lipid-protein
interface of ApoA-II/DMPC both change polarity during a
phase transition (Massey et al., 1985c; Pownall et al., 1978).
Similarly, the physical state of the phospholipid in the
complex affects the microenvironment and chemical reac-
tivity of the chromanol -tocopherol.
DMPC in model HDLs consists of a “boundary” lipid,
which is directly associated with protein and does not un-
dergo a gel-to-liquid crystalline phase transition, and a
“bulk” lipid, which is not in contact with protein and has
properties similar to those of DMPC in liposomes. Previous
physical studies (Massey et al., 1985b; Nakagaki et al.,
1985; Silvius et al., 1984) suggest a model in which cho-
lesterol is excluded from the boundary lipid because of poor
packing of the rigid sterol moiety among the lipids and the
irregular protein surface. Phosphatidylcholine (PC), which
has a great deal of flexibility in its acyl chains, can be
readily accommodated by the protein surface. Like PC,
-tocopherol is more flexible than cholesterol (Ekiel et al.,
1988). The concentration-dependent increase in fluores-
cence polarization and decreased acyl chain mobility sug-
gest that within a fluid-lipid matrix, -tocopherol is distrib-
uted throughout both the bulk and boundary lipid. The lack
of effect of -tocopherol on polarization below TC suggests
that -tocopherol behaves as an impurity that is “frozen
out” of the DMPC molecules that undergo a phase transition
into the boundary region. This would be consistent with the
effect of -tocopherol in saturated PC bilayers, where it is
preferentially excluded from the gel-phase lipids (Villalain
et al., 1986; Ortiz et al., 1987; Massey et al., 1982).
Other studies have suggested that the spontaneous asso-
ciation of apolipoproteins with DMPC is a function of
surface permeability, that association occurs by means of
the insertion of ApoA-I into preexisting defects in the lipid
surface, and that the rate of association is a direct function
of the number of defects in the lipid surface. According to
this model, the defects form at the boundary between two
different lipid phases. In pure DMPC at its transition tem-
perature, defects occur between gel and liquid-crystalline
phase lipids (Pownall et al., 1978; Reijngould and Phillips,
1984); in the presence of cholesterol, defects form between
domains of pure DMPC and those that are cholesterol rich
(Pownall et al., 1979, 1987; Estep et al., 1978; Genz et al.,
1986). The number of defects is maximal at the gel-liquid
crystalline transition of the lipid (Pownall et al., 1978;
Reijngould and Phillips, 1984) and is increased by the
addition of up to 12 mol % cholesterol. Consequently, the
rate of association is highest at the transition temperature of
DMPC that contains 12 mol % cholesterol (Pownall et al.,
1979). The effects of -tocopherol on the properties of
DMPC and the kinetics of association of ApoA-I and
DMPC are distinct from those of cholesterol. As with
DMPC and cholesterol-DMPC mixtures, the maximal rate
of association with ApoA-I occurred at the lipid transition
temperature. In contrast to cholesterol, the addition of -to-
copherol lowered rather than raised the transition tempera-
ture of DMPC (Massey et al., 1982). Thus, as the amount of
-tocopherol increases the temperature at which the maxi-
mal rate of association occurs decreases. In addition, -to-
copherol inhibits the association of ApoA-I and DMPC in a
dose-dependent manner (Figs. 1 and 2 A).
The inhibition could be either kinetically or thermody-
namically controlled. Several studies have shown that the
composition and properties of model HDLs formed by
spontaneous association of ApoA-I and DMPC are identical
to those formed by combining ApoA-I and lipids with a
detergent followed by removal of the detergent (Massey et
al., 1985b; Matz and Jonas, 1982; Pownall et al., 1982).
Detergent removal methods “catalyze” the assembly of lip-
ids and proteins under conditions in which spontaneous
assembly is slow or does not occur, for example, above or
below the transition temperature or in the presence of high
cholesterol concentrations. As the cholate dialysis proce-
dure leads to quantitative incorporation of ApoA-I, DMPC,
and -tocopherol into homogeneous model HDLs, their
formation in the absence of a detergent must be kinetically
controlled. The decreased rate of association of ApoA-I
with DMPC observed with increasing -tocopherol is prob-
ably due to a decrease in the number of defects in the lipid
surface. Defects in lipid bilayers permit entrapped small
molecules to escape. Previous experiments (Halks-Miller et
al., 1985) have shown that addition of -tocopherol to
phospholipid liposomes decreases the rate at which a
trapped dye escapes, suggesting that -tocopherol decreases
the size and/or number of surface defects. Our data are
consistent with this observation and, according to the model
in which the rate association of ApoA-I with DMPC is a
function of the number of surface defects, the decrease in
the rate of association seen with increasing -tocopherol
would have been predicted.
It is interesting to compare the structures of -tocopherol
and cholesterol and ask why one would increase the number
of defects and the other would not. According to the phys-
icochemical studies, cholesterol induces phase separation in
lipid bilayers, whereas -tocopherol does not (Lucy, 1978;
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Lai et al., 1985; Wasall et al., 1986; Villalain et al., 1986;
Ortiz et al., 1987; Massey et al., 1982; Ekiel et al., 1988).
Both cholesterol and -tocopherol contain a hydroxyl group
that anchors that part of the molecule at the lipid-water
interface. The remainder of the molecule is inserted into the
hydrocarbon region of the lipid. Cholesterol is a flat, rigid
molecule with a shape that is roughly that of a truncated
cone in which the smaller end resides at the lipid-water
interface (Israelachvili et al., 1980). Cholesterol does not
pack into the DMPC-ApoA-I matrix efficiently because of
its shape and its inability to flex into a more accommodating
shape. As a consequence of the poor packing, cholesterol
creates defects in the surface. On the other hand, -tocoph-
erol is nearly cylindrical and contains a long, flexible phytyl
chain that can be rotated or bent to pack closely with the
phospholipid acyl chains. As the difference in the shapes of
cholesterol and -tocopherol are small, it is likely that the
high degree of flexibility within the phytyl chain permits
-tocopherol to insert into defects in the DMPC bilayer,
reducing the number and size of defects. As the rate asso-
ciation of ApoA-I with DMPC is a function of the number
of defects, incorporation of -tocopherol into the bilayer is
associated with a lower rate of DMPC-ApoA-I association.
Cholesterol alters physiological activities directly by a
molecular interaction or indirectly by altering membrane
fluidity (Gimpl et al., 1997) and polarity (Massey et al.,
1985c). In the presence of high HDL levels, HDL and not
LDL is the major plasma carrier of -tocopherol (Traber et
al., 1992; Clevidence and Lehman, 1989). However, even in
subjects using dietary supplements containing -tocopherol,
plasma -tocopherol concentrations are much lower than
those of cholesterol and vary from 5.4 to 24.0 g/ml. These
respective levels correspond to 0.5 and 3 mol % -to-
copherol in HDLs. According to our data, these amounts of
-tocopherol in a cell membrane or plasma lipoprotein are
too low to alter any activity that is a function of fluidity or
of the polarity of the lipid surface. However, according to
our kinetic data (Fig. 8), these -tocopherol levels could be
an important determinant of the rates of association of
apolipoproteins with HDLs, so that the plasma concentra-
tion of unbound ApoA-I may be increased in response to
high plasma -tocopherol levels.
Although -tocopherol is antioxidant in a variety of tis-
sues and fluids, current evidence suggests that -tocopherol
exerts its other physiologic effects in cells, not plasma
lipoproteins (Devaraj and Jialal, 1998). Within cell mem-
branes, -tocopherol could form -tocopherol-rich domains
(Sa´nchez-Migallo´n et al., 1996) and co-localize with other
membrane-bound molecules that regulate cellular activities.
These activities include inhibition of platelet aggregation
(Freedman et al., 1996), inhibition of protein kinase C
(Devaraj and Jialal, 1998; Freedman et al., 1996), and
modulation of cytosolic phospholipase A2 activity (Tran et
al., 1996). Our data provide several possible mechanisms by
which -tocopherol could alter lipid structure within a mi-
croenvironment. These mechanisms include filling in de-
fects within lipids or between lipids and proteins and reduc-
ing the local fluidity. However, many of these effects are
small or require large amounts of -tocopherol. Therefore,
it is likely that many of the effects of -tocopherol occur
through specific interactions with cellular proteins.
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